Squaric-acid-engineered FAP2286: A next-generation 68Ga/177Lu theranostic ligand with synergistically enhanced affinity, hydrophilicity, and tumor retention.

lutetium Lu 177 rofapitide tetraxetan (AAA614) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/41177127

Dongkun Xu; Jianpeng Cao; Lina Liu; Qian Liu; Quanyu Zhou; Wenling Tu; Xue Jiang; Yin Huang; Yue Chen; Yuhong Shi; Yuxiao Xia

Nov 3, 2025